The Structural Basis of Estrogen Receptor/Coactivator Recognition and the Antagonism of This Interaction by Tamoxifen

Adams, 1997, Cross-validated maximum likelihood enhances crystallographic simulated annealing refinement, Proc. Natl. Acad. Sci. USA, 94, 5018, 10.1073/pnas.94.10.5018

Anzick, 1997, AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer, Science, 277, 965, 10.1126/science.277.5328.965

Beato, 1995, Steroid hormone receptors, Cell, 83, 851, 10.1016/0092-8674(95)90201-5

Berry, 1990, Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen, EMBO J., 9, 2811, 10.1002/j.1460-2075.1990.tb07469.x

Bourguet, 1995, Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α, Nature, 375, 377, 10.1038/375377a0

Brünger, 1996

Brzozowski, 1997, Molecular basis of agonism and antagonism in the oestrogen receptor, Nature, 389, 753, 10.1038/39645

CCP4, 1994, The CCP4 suite, Acta Crystallogr. D, 50, 760, 10.1107/S0907444994003112

Chen, 1997, Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300, Cell, 90, 569, 10.1016/S0092-8674(00)80516-4

Danielian, 1992, Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors, EMBO J., 11, 1025, 10.1002/j.1460-2075.1992.tb05141.x

Ding, 1998, Nuclear receptor-binding sites of coactivators glucocorticoid receptor interacting protein 1 (GRIP1) and steroid receptor coactivator 1 (SRC-1), Mol. Endocrinol., 12, 302, 10.1210/mend.12.2.0065

Esnouf, 1997, An extensively modified version of MolScript that includes greatly enhanced coloring capabilities, J. Mol. Graph. Model., 15, 132, 10.1016/S1093-3263(97)00021-1

Feng, 1998, Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors, Science, 280, 1747, 10.1126/science.280.5370.1747

Furey, 1990, PA33, Am. Cryst. Assoc. Mtg. Abstr., 18, 73

Glass, 1997, Nuclear receptor coactivators, Curr. Opin. Cell Biol., 9, 222, 10.1016/S0955-0674(97)80066-X

Gradishar, 1997, Clinical potential of new antiestrogens, J. Clin. Oncol., 15, 840, 10.1200/JCO.1997.15.2.840

Grainger, 1996, Tamoxifen, Nat. Med., 2, 381, 10.1038/nm0496-381

Greene, 1980, Monoclonal antibodies to human estrogen receptor, Proc. Natl. Acad. Sci. USA, 77, 5115, 10.1073/pnas.77.9.5115

Greene, 1988, Purification of T47D human progesterone receptor and immunochemical characterization with monoclonal antibodies, Mol. Endocrinol., 2, 714, 10.1210/mend-2-8-714

Grese, 1997, Molecular determinants of tissue selectivity in estrogen receptor modulators, Proc. Natl. Acad. Sci. USA, 94, 14105, 10.1073/pnas.94.25.14105

Hanstein, 1996, p300 is a component of an estrogen receptor coactivator complex, Proc. Natl. Acad. Sci. USA, 93, 11540, 10.1073/pnas.93.21.11540

Heery, 1997, A signature motif in transcriptional co-activators mediates binding to nuclear receptors, Nature, 387, 733, 10.1038/42750

Hegy, 1996, Carboxymethylation of the human estrogen receptor ligand-binding domain-estradiol complex, Steroids, 61, 367, 10.1016/0039-128X(96)00042-6

Henttu, 1997, AF-2 activity and recruitment of steroid receptor coactivator 1 to the estrogen receptor depend on a lysine residue conserved in nuclear receptors, Mol. Cell. Biol., 17, 1832, 10.1128/MCB.17.4.1832

Hong, 1996, GRIP1, a novel mouse protein that serves as a transcriptional coactivator in yeast for the hormone binding domains of steroid receptors, Proc. Natl. Acad. Sci. USA, 93, 4948, 10.1073/pnas.93.10.4948

Horwitz, 1996, Nuclear receptor coactivators and corepressors, Mol. Endocrinol., 10, 1167

Huang, 1991, Conic, J. Mol. Graph., 9, 230, 10.1016/0263-7855(91)80016-S

Jordan, 1998, Antiestrogenic action of raloxifene and tamoxifen, J. Natl. Cancer Inst., 90, 967, 10.1093/jnci/90.13.967

Jordan, 1982, Importance of the alkylaminoethoxy side-chain for the estrogenic and antiestrogenic actions of tamoxifen and trioxifene in the immature rat uterus, Mol. Cell. Endocrinol., 27, 291, 10.1016/0303-7207(82)90095-8

Kamei, 1996, A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors, Cell, 85, 403, 10.1016/S0092-8674(00)81118-6

Kato, 1995, Activation of the estrogen receptor through phosphorylation by mitogen-actived protein kinase, Science, 270, 1491, 10.1126/science.270.5241.1491

Kleywegt, G.J., and Jones, T.A. (1994). Halloween…masks and bones. In From First Map to Final Model, S. Bailey, R. Hubbard, and D. Waller, eds. (Warrington, England: SERC Daresbury Laboratory).

Korach, 1994, Insights from the study of animals lacking functional estrogen receptor, Science, 266, 1524, 10.1126/science.7985022

Kuiper, 1997, Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta, Endocrinology, 138, 863, 10.1210/endo.138.3.4979

Kumar, 1987, Functional domains of the human estrogen receptor, Cell, 51, 941, 10.1016/0092-8674(87)90581-2

Le Douarin, 1996, A possible involvement of TIF1 alpha and TIF1 beta in the epigenetic control of transcription by nuclear receptors, EMBO J., 15, 6701, 10.1002/j.1460-2075.1996.tb01060.x

Li, 1997, RAC3, a steroid/nuclear receptor-associated coactivator that is related to SRC-1 and TIF2, Proc. Natl. Acad. Sci. USA, 94, 8479, 10.1073/pnas.94.16.8479

Merritt, 1994, Raster3D Version 2.0, Acta Crystallogr. D, 50, 219, 10.1107/S0907444994006396

Moras, 1998, The nuclear receptor ligand-binding domain, Curr. Opin. Cell Biol., 10, 384, 10.1016/S0955-0674(98)80015-X

Muller, 1988, MOLOC, Bull. Soc. Chim. Belg., 97, 655

Murshudov, 1997, Refinement of macromolecular structures by the maximum-likelihood method, Acta Crystallogr. D, 53, 240, 10.1107/S0907444996012255

Nicholls, 1991, Protein folding and association, Proteins, 11, 281, 10.1002/prot.340110407

Norris, 1998, Enhancement of estrogen receptor transcriptional activity by the coactivator GRIP-1 highlights the role of activation function 2 in determining estrogen receptor pharmacology, J. Biol. Chem., 273, 6679, 10.1074/jbc.273.12.6679

Onate, 1995, Sequence and characterization of a coactivator for the steroid hormone receptor family, Science, 270, 1354, 10.1126/science.270.5240.1354

Otwinowski, 1997, Processing of x-ray diffraction data collected in oscillation mode, Methods Enzymol., 276, 307, 10.1016/S0076-6879(97)76066-X

Renaud, 1995, Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid, Nature, 378, 681, 10.1038/378681a0

Robertson, 1982, Antiestrogen basicity—activity relationships, J. Med. Chem., 25, 167, 10.1021/jm00344a015

Seielstad, 1995, Molecular characterization by mass spectrometry of the human estrogen receptor ligand-binding domain expressed in Escherichia coli, Mol. Endocrinol., 9, 647

Smigel, 1998, Breast cancer prevention trial shows major benefit, some risk, J. Natl. Cancer Inst., 90, 647, 10.1093/jnci/90.9.647

Smith, 1994, Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man, N. Engl. J. Med., 331, 1056, 10.1056/NEJM199410203311604

Tanenbaum, 1998, Crystallographic comparison of the estrogen and progesterone receptor's ligand binding domains, Proc. Natl. Acad. Sci. USA, 95, 5998, 10.1073/pnas.95.11.5998

Tora, 1989, The cloned human oestrogen receptor contains a mutation which alters its hormone binding properties, EMBO J., 8, 1981, 10.1002/j.1460-2075.1989.tb03604.x

Torchia, 1997, The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function, Nature, 387, 677, 10.1038/42652

Tsai, 1994, Molecular mechanisms of action of steroid/thyroid receptor superfamily members, Annu. Rev. Biochem., 63, 451, 10.1146/annurev.bi.63.070194.002315

Voegel, 1996, TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors, EMBO J., 15, 3667, 10.1002/j.1460-2075.1996.tb00736.x

Voegel, 1998, The coactivator TIF2 contains three nuclear receptor-binding motifs and mediates transactivation through CBP binding-dependent and -independent pathways, EMBO J., 17, 507, 10.1093/emboj/17.2.507

Wallace, 1995, LIGPLOT, Protein Eng., 8, 127, 10.1093/protein/8.2.127

Wrenn, 1993, Structure-function analysis of the hormone binding domain of the human estrogen receptor by region-specific mutagenesis and phenotypic screening in yeast, J. Biol. Chem., 268, 24089, 10.1016/S0021-9258(20)80497-9

Wurtz, 1996, A canonical structure for the ligand-binding domain of nuclear receptors, Nat. Struct. Biol., 3, 87, 10.1038/nsb0196-87